Related by context. All words. (Click for frequent words.) 80 covariate 79 potential confounders 77 confounders 76 multivariate logistic regression 76 multivariate analyzes 75 multivariate analysis 74 logistic regression model 74 sociodemographic factors 73 univariate 73 confounding variables 71 sociodemographic 71 univariate analysis 70 confounding factors 70 logistic regression 70 sociodemographic variables 70 multiple logistic regression 70 logistic regression models 69 logistic regression analysis 69 sociodemographic characteristics 69 univariate analyzes 69 Logistic regression 68 prognostic factors 68 multivariable analysis 68 multivariate Cox 67 conditional logistic regression 67 demographic variables 67 stepwise logistic regression 67 comorbidities 67 comorbidity 66 logistic regression analyzes 66 potential confounding variables 66 Univariate 65 odds ratios ORs 65 MMSE score 65 regression analyzes 65 proportional hazards 65 Logistic regression analysis 65 Multivariate analysis 65 potentially confounding variables 65 bivariate analyzes 64 multivariable logistic regression 64 comorbid conditions 64 multivariable Cox 64 multivariable analyzes 64 BMI z 63 Poisson regression 63 Univariate analysis 63 metabolic parameters 63 predictor variables 63 Bonferroni correction 63 APOE genotype 63 confidence intervals CIs 63 tertiles 63 multivariate regression 63 Subgroup analyzes 62 bivariate 62 MetS 62 residual confounding 62 multivariate adjustment 62 generalized estimating 62 binary logistic regression 62 explanatory variables 62 multivariate regression analysis 62 multivariable adjusted 62 meta regression 61 prospectively defined 61 logistic regressions 61 nonfatal MI 61 CVD mortality 61 symptomatic intracerebral hemorrhage 61 prognostic variables 61 ANOVA 61 depressive symptomatology 61 HRQL 61 posttreatment 61 intima media thickness 61 Secondary efficacy endpoints 60 autonomic dysfunction 60 socioeconomic variables 60 multivariable 60 % CI #.#-#.# [006] 60 Multivariate logistic regression 60 psychiatric comorbidities 60 MDRD 60 HOMA IR 60 physiologic parameters 60 HbA 1c levels 60 postintervention 60 multiple linear regression 60 Kaplan Meier analysis 60 biochemical recurrence 60 confidence interval CI 60 ANCOVA 60 bivariate analysis 59 confounder 59 hormone receptor status 59 Secondary endpoints 59 HbA 1c 59 endometrial thickness 59 subgroup analyzes 59 psychiatric comorbidity 59 antidiabetic medications 59 metabolite concentrations 59 subscales 59 HbA1C levels 59 comorbid 59 HRQoL 59 serum estradiol 59 tertile 59 allele frequencies 59 fasting insulin 59 genotypic resistance 59 Multiple logistic regression 59 neurocognitive functioning 58 comorbid depression 58 preoperative PSA 58 Kaplan Meier curves 58 depressive symptom 58 Multivariate analyzes 58 socioeconomic status 58 serum IGF 58 mammographic density 58 Exclusion criteria 58 multivariable adjustment 58 carotid IMT 58 tumor histology 58 Subgroup analysis 58 IPAH 58 CHD mortality 58 Primary endpoints 58 serum concentrations 58 genetic polymorphisms 58 coronary stenosis 58 androgen suppression 58 NHANES III 58 etiologic 58 NIHSS score 58 Baseline characteristics 58 colorectal adenoma 58 Multiple linear regression 58 Brief Psychiatric 58 highest tertile 58 inflammatory biomarkers 58 subscale scores 58 airway responsiveness 58 Kaplan Meier survival 58 TEAEs 58 HER2 expression 58 multivariate 58 Reynolds Risk Score 57 chronicity 57 CrCl 57 exploratory endpoints 57 CORE OM 57 Linear regression 57 socio demographic 57 adiponectin concentrations 57 timepoints 57 plasma lipids 57 HRQOL 57 P = .# 57 variables 57 % CI #.#-#.# [002] 57 hip BMD 57 warfarin dosage 57 F FDG PET 57 hemodynamic parameters 57 Postoperative complications 57 histologic subtype 57 interobserver reliability 57 syndromal 57 proband 57 albumin excretion 57 spirometric 57 postoperative AF 57 Child Behavior Checklist 57 Sociodemographic 57 advanced neoplasia 57 MDRD equation 57 salivary cortisol 57 alexithymia 57 premorbid 57 Depressive symptoms 57 linear regression analyzes 57 estimated glomerular filtration 57 meta analytic 57 Kaplan Meier method 57 Montgomery Åsberg Depression 57 systolic BP 57 unmeasured confounders 57 nonobese 57 adenotonsillectomy 57 prospective cohort 57 thyroid hormone levels 57 subclinical atherosclerosis 57 nonsignificant 57 nonparametric 57 intact parathyroid hormone 57 intraobserver 57 randomized controlled trials RCTs 57 Index CDAI 57 serum testosterone 57 antihypertensive medication 57 Regression analyzes 57 serum cortisol 57 parous women 57 symptomatic VTE 56 ALT flares 56 unfavorable prognostic 56 CYP#D# genotype 56 TT genotype 56 estimated GFR 56 virologic failure 56 hsCRP levels 56 statistically nonsignificant 56 euthymic patients 56 neurocognitive impairment 56 serum PTH 56 covariance 56 glycated hemoglobin levels 56 neurocognitive function 56 CHADS2 56 preintervention 56 Kruskal Wallis test 56 Glomerular filtration rate 56 nondiabetic patients 56 affective disorders 56 poststroke 56 serum lactate 56 Main Outcome Measures 56 linear regression analysis 56 chi squared 56 thyrotropin levels 56 serum calcium 56 tHcy 56 secondary efficacy endpoint 56 virological response 56 subclinical hypothyroidism 56 prostate cancer CaP 56 obstructive coronary artery 56 retrospective cohort 56 gene polymorphisms 56 T2D 56 BMD measurements 56 p = .# [002] 56 cTnT 56 genotypic 56 Descriptive statistics 56 variance ANOVA 56 strongest predictor 56 FDG PET scans 56 dysglycemia 56 SUVmax 56 diastolic pressures 56 NNRTI resistance 56 postoperative complication 56 definite stent thrombosis 56 serum retinol 56 creatinine ratio 56 EQ 5D 56 covariance ANCOVA 56 β = 56 antenatal depression 56 subscores 56 predictors 56 prognostic indicators 56 Multivariable logistic regression 56 psychosocial variables 56 telomere lengths 56 Rating Scale BPRS 56 familial aggregation 56 confidence interval #.#-#.# 56 histological subtype 56 demographic characteristics 56 serum GGT 56 PSADT 56 pharmacodynamic parameters 56 regression equations 56 Meta analyzes 56 psychiatric morbidity 56 aspartate aminotransferase AST 56 semiquantitative 56 postdischarge 56 CI = 56 serum lipid levels 56 DSM IV diagnosis 56 macroalbuminuria 56 normotensive 55 serum creatinine levels 55 QTc prolongation 55 rs# [004] 55 macrovascular disease 55 posttransplant 55 Hb A1C 55 clinico pathological 55 recursive partitioning 55 atherogenic dyslipidemia 55 HbA1c levels 55 prevalences 55 cerebral microbleeds 55 clinicopathological 55 shorter telomere length 55 apolipoprotein B 55 β blockers 55 lipid parameters 55 plasma cortisol 55 posttest 55 nondepressed 55 regression analysis 55 causal pathway 55 baseline HbA1c 55 symptom severity 55 susceptibility loci 55 neurodevelopmental outcome 55 T2DM 55 antihypertensive medications 55 lowest tertile 55 hsCRP 55 glomerular filtration rate 55 aminotransferases 55 nodal metastases 55 laboratory abnormalities 55 SGRQ 55 MGUS 55 Socioeconomic status 55 Secondary endpoints included 55 comorbid psychiatric 55 adenoma recurrence 55 Apgar scores 55 FEV ^ sub 55 MADRS score 55 serum cotinine 55 mRNA expression 55 clinicopathological features 55 colorectal neoplasia 55 Multivariate 55 Bonferroni 55 polygenic 55 creatinine clearance 55 liver transplant recipients 55 ROC curves 55 premenopausal 55 myocardial viability 55 lymph node metastasis 55 subclinical hyperthyroidism 55 lipid lowering therapy 55 potentially modifiable 55 psychosocial functioning 55 SNP rs# [002] 55 plasma homocysteine 55 plasma glucose 55 alanine aminotransferase ALT 55 QIDS SR 55 fasting plasma 55 femoral neck fracture 55 Multivariable 55 strongest predictors 55 oxygen desaturation 55 antihypertensive therapy 55 coinfected patients 55 familial AF 55 mL/min/#.# m 2 55 hypoglycemic events 55 neurodevelopmental impairment 55 eGFR 55 electroencephalographic 55 locoregional 55 % CI #.#-#.# [008] 55 APACHE II 55 co morbidities 55 SCr 55 psychopathological symptoms 55 carotid intima media 55 urinary albumin 55 menarche 55 prognostic factor 55 unmeasured factors 55 fasting serum 55 urine albumin 55 GnRH agonist 55 cardiometabolic risk 55 serum PSA 55 microalbuminuria 55 DAS# scores 55 serum potassium 55 aminotransferase levels 55 p = #.# [002] 55 surrogate markers 55 cortical activation 55 serum creatinine 55 beta blocker therapy 54 lipid abnormalities 54 metabolic abnormalities 54 recurrent venous thromboembolism 54 hemoglobin A1c levels 54 plasma folate 54 pCR 54 differential gene expression 54 thyroid stimulating hormone 54 hematologic toxicity 54 leukocyte counts 54 internalizing behaviors 54 nomograms 54 secondary efficacy endpoints 54 LUTS 54 CC genotype 54 LVSD 54 QoL 54 Kaplan Meier curve 54 affective psychosis 54 somatoform disorders 54 prospective observational studies 54 EDSS score 54 cTnT levels 54 endometrial carcinoma 54 #q# deletion syndrome 54 Secondary endpoints include 54 body fatness 54 ABCB1 54 COMT genotype 54 cardioembolic stroke 54 NYHA functional class 54 Symptom severity 54 echocardiographic parameters 54 plasma pharmacokinetics 54 adiposity 54 OGTT 54 albumin excretion rate 54 glycosylated hemoglobin HbA1c 54 lipid profiles 54 chest radiographs 54 poor metabolizers 54 postmenopausal hormone 54 nonfasting triglyceride levels 54 systolic dysfunction 54 HAQ DI 54 unipolar depression 54 haematologic 54 HAM D# 54 sociodemographics 54 Insulin sensitivity 54 pairwise comparisons 54 regression coefficient 54 CYP#D# inhibitor 54 lipid lowering agents 54 serum HBV DNA 54 quartiles 54 glycosylated hemoglobin 54 symptom exacerbation 54 index BMI 54 plasma glucose concentration 54 adenocarcinoma histology 54 comorbid illnesses 54 hypertensives 54 inotropic 54 DAS# [002] 54 generalized linear 54 fasting glucose levels 54 aldosterone antagonist 54 depressive symptoms 54 PCa 54 postoperative mortality 54 concomitant medications 54 coronary calcification 54 composite endpoint 54 periprocedural 54 serum leptin 54 HDRS 54 specific antigen PSA 54 glycemia 54 VKORC1 54 elevated ALT 54 Efficacy endpoints 54 airway hyperresponsiveness 54 rheumatoid factor 54 preoperatively 54 histopathologic diagnosis 54 carotid plaques 54 BMI percentile 54 Socio demographic 54 probands 54 overt nephropathy 54 d dimer 54 karyotypes 54 convergent validity 54 comorbid disorders 54 fraternal twin pairs 54 Incontinence Impact Questionnaire 54 prespecified 54 LV dysfunction 54 suicide attempters 54 rs# [001] 54 hippocampal volume 54 hypercholesterolemia 54 lignan intake 54 parasitaemia 54 adenomatous polyps 54 liver biopsies 54 Prehypertension 54 serum uric acid 54 nonfatal myocardial infarction 54 hepatic enzyme 54 bronchopulmonary dysplasia 54 visceral adiposity 54 perinatal outcomes 54 carotid artery thickness 54 somatic symptoms 54 Charlson comorbidity index 54 % CI #.#-#.# [007] 54 Interrater reliability 54 triacylglycerol concentrations 54 platelet reactivity 54 dimensional echocardiography 54 PSQI 54 histopathological 54 laterality 54 loop diuretics 54 NMIBC 54 extramedullary 54 ADAS cog 53 coronary artery calcification 53 HER2 overexpression 53 % CI #.#-#.# [004] 53 preoperative 53 perinatal complications 53 ethnicity socioeconomic status 53 hyperbilirubinemia 53 virologic responses 53 aneurysmal subarachnoid hemorrhage 53 inhibin B 53 AST ALT 53 chi ^ sup 53 vertebral fracture 53 serum cotinine levels 53 subscore 53 fasting glucose 53 bulimia nervosa 53 familial clustering 53 mesalamine granules 53 differentially expressed genes 53 Scale EDSS score 53 recurrent VTE 53 APTIVUS r 53 genetic loci 53 analgesic medications 53 neuropsychological assessment 53 plasma triglycerides 53 LV ejection fraction 53 % CI #.#-#.# [003] 53 isoprostane 53 comorbid anxiety 53 relapsed MM 53 oral hypoglycemic agents 53 serum markers 53 serum phosphate 53 thromboembolism 53 pretransplant 53 nonpregnant women 53 K ras mutations 53 nulliparous women 53 serum vitamin D 53 femoral neck BMD 53 n = 53 hypertension diabetes mellitus 53 nondiabetic 53 perioperative complications 53 virological failure 53 Main Outcome Measure 53 EDSS scores 53 Kaplan Meier 53 eplerenone 53 prognostic significance 53 electrophysiologic 53 albumin creatinine ratio 53 ziprasidone 53 Logistic regression models 53 PSA nadir 53 node metastases 53 adverse perinatal 53 EGFR mutation status 53 Pharmacokinetic parameters 53 baseline LDH 53 highest quintile 53 hepatic function 53 leukocyte count 53 HIV seroconversion 53 CYP#D# 53 lipoprotein levels 53 elevated fasting glucose 53 externalizing behaviors 53 baseline FEV 53 observational cohort 53 Pearson correlation coefficients 53 System IPSS 53 Framingham Offspring Study 53 Observational studies 53 cardio respiratory fitness 53 left ventricular dysfunction 53 CTEPH 53 FeNO 53 PCWP 53 attain statistical significance 53 RCTs 53 stepwise regression 53 Cystatin C 53 tumor necrosis 53 hypothalamic pituitary 53 anthropometric measures 53 rCBF 53 elevated LDH 53 coronary revascularization 53 hierarchical clustering 53 Serum creatinine 53 hydroxyvitamin D levels 53 prepregnancy BMI 53 stratifying patients 53 atopy 53 exhaled nitric oxide 53 interobserver 53 serum albumin 53 amenorrhoea 53 unpaired t 53 dietary patterns 53 ECG abnormalities 53 paricalcitol 53 Crohn Disease Activity 53 nucleotide substitutions 53 HRCT 53 serum HCV RNA 53 fasting plasma glucose 53 clomipramine 53 serum testosterone levels 53 arterial oxygen saturation 53 HIV HCV coinfected 53 mg kg dose 53 FDG PET 53 carotid atherosclerosis 53 prespecified secondary 53 HAART regimens 53 p = NS 53 glycated hemoglobin HbA1c 53 epithelial ovarian cancer 53 advanced adenoma 53 hypopneas 53 cytologic 53 baseline CD4 53 subtrochanteric 53 nomogram 53 correlation coefficients 53 NIHSS 53 genetic variants associated 53 pretest probability 53 Variables 53 dosage regimens 53 β blocker 53 QTc interval 53 hip resurfacing arthroplasty 53 pharmacokinetics PK 53 HDL cholesterol triglycerides 53 WOMAC pain 53 VLBW infants 53 irregular menses 53 unmeasured confounding 53 timepoint 53 proteinuria 53 seropositivity 53 mRS 53 schizophreniform disorder 53 parkinsonism 53 interrater reliability 53 SHBG levels 53 gallstone disease 53 serum lipids 53 nonpsychotic 53 SE alleles 53 allelic 53 PSA kinetics 53 statistical significance p 53 hypoxemia 53 rs# [003] 53 advanced adenomas 53 Alzheimer Disease Assessment 53 COPD exacerbation 53 creatinine levels 53 pulmonary exacerbations 53 hypoglycemic episodes 53 glycosylated hemoglobin levels 53 asthma exacerbation 53 scintigraphic 53 albuminuria 53 clinically localized prostate 53 parous 53 lifetime abstainers 53 thyrotropin 53 biochemical relapse 53 antioxidant supplementation 53 UACR 52 Heritability 52 Structured Clinical 52 Female Sexual Function 52 inhospital mortality 52 UPDRS 52 carotid bruit 52 overt hypothyroidism 52 MMSE scores 52 MS DRG 52 serum homocysteine 52 cardiovascular mortality 52 erection hardness 52 lymph node involvement 52 p = 52 immunostaining 52 urinary albumin excretion 52 plasma selenium 52 dietary questionnaires 52 atypical hyperplasia 52 histopathologic 52 serum glucose 52 liver histology 52 Mantel Haenszel 52 CI -#.# 52 kidney allograft 52 LDL HDL 52 p = #.# [003] 52 left ventricular systolic 52 serum calcium levels 52 Y BOCS 52 sleeve lobectomy 52 antidiabetic medication 52 waist circumference WC 52 orofacial clefts 52 CR nPR 52 cerebral infarction 52 distant metastasis 52 dyslipidemia hypertension 52 BCR ABL mutations 52 SGAs 52 Visual Analogue Scale VAS 52 renal cysts 52 creatinine clearance CrCl 52 cystatin C 52 Kaplan Meier estimates 52 methacholine challenge 52 statistically significant differences 52 hemoglobin Hb 52 antiretroviral regimen 52 abdominal circumference 52 cotinine levels 52 HIV uninfected 52 Comorbidity 52 PLMs 52 androgen deprivation 52 Multivariate analysis revealed 52 ejection fractions 52 NIH CPSI 52 curative resection 52 Scale EDSS 52 peak VO2 52 prognostic markers 52 DSM IV SCID 52 umol L 52 plasma creatinine 52 categorical variables 52 Hemodynamic 52 adnexal mass 52 dietary folate intake 52 overnight polysomnography 52 dichotomous variables 52 BMI ≥ 52 morbidities 52 EPDS 52 ß = 52 ventricular hypertrophy 52 nonvertebral fractures 52 ATACAND 52 apnea hypopnea index 52 SHBG 52 desvenlafaxine succinate 52 hyperinsulinemic euglycemic clamp 52 Fasting glucose 52 T1DM 52 trials RCTs 52 serum lipid 52 cognitive affective 52 ADCS ADL 52 hepatic cirrhosis 52 ADAS Cog 52 CYP#C# [001] 52 epistasis 52 μmol L 52 aortic atherosclerosis 52 BEXXAR Therapeutic Regimen 52 Predictors 52 amisulpride 52 -#.# ± [002] 52 ACR Pedi 52 systolic blood pressure 52 plasma renin 52 callous unemotional traits 52 adrenal function 52 dopamine receptor gene 52 bile acid metabolism 52 Suicidal ideation 52 CIN2 + 52 HSCT 52 YMRS 52 linear regression models 52 bronchial reactivity 52 maximal treadmill 52 ECOG PS 52 apnea hypopnea 52 euthymic 52 D dimer 52 systolic blood pressures 52 PAEE 52 BMI waist circumference 52 pathologic fractures 52 elevated IOP 52 inhaled corticosteroid therapy 52 SRBD 52 socioeconomic deprivation 52 prognostic biomarker 52 glomerular filtration 52 glucose insulin 52 tipranavir r 52 nonoperative treatment 52 anti Mullerian hormone 52 histologically confirmed 52 renal function 52 HbA 1C 52 serum folate 52 dietary intakes 52 obstetric complications 52 CYP#D# gene 52 Complication rates 52 heterozygotes 52 QTc intervals 52 neuroleptic 52 waist girth 52 echocardiographic 52 abnormal lipid 52 prepregnancy 52 colorectal adenomas 52 lipid lowering drugs 52 QALE 52 angiographic outcomes 52 neuropsychological deficits 52 sensory gating 52 hepatic fat 52 Regression analysis 52 DLTs 52 hematological parameters 52 endophenotypes 52 plasma adiponectin 52 diastolic blood pressures 52 EBRT 52 ADCS CGIC 52 serum phosphate levels 52 Postoperative 52 nonvertebral fracture 52 morphometric vertebral fractures 52 inotropic agents 52 genomewide 52 pharmacokinetic parameters 52 nonrandomized 52 perioperative morbidity 52 Lp PLA 2 52 PERMP 52 detrusor overactivity 52 International Prostate Symptom 52 adjuvant systemic 52 rho = 52 pharmacodynamic markers 52 MMSE 52 postmenopausal estrogen 52 INTERHEART study 52 Subgroups 52 sonographic findings 52 breast carcinoma 52 Expanded Disability Status 52 airflow obstruction 52 ventilation perfusion 52 dietary calcium intake 52 comorbid diagnoses 52 Montgomery Asberg Depression 52 fructosamine 52 handgrip strength 52 pharmacodynamic endpoints 52 virologically 52 diastolic BP 52 WOMAC scores 52 RE LY ® 52 Endothelial function 52 nonadherence 52 Score DAS# 52 serum urate 52 anti JCV antibodies 52 rhGH 52 Breslow thickness 52 left ventricular hypertrophy 52 symptomatology 52 nodal metastasis 52 Framingham Risk Score 52 venous thromboembolic disease 52 inhibin 52 impaired glucose metabolism 52 amenorrhea 52 serum ferritin 52 IgG antibody 52 longitudinal observational study 52 anthropometric measurements 52 RRM1 52 dyssynchrony 52 fibrinolysis 52 lipid levels 52 Inhibin B 52 lowest quintile 52 histologic subtypes 52 obstructive CAD 52 serous ovarian cancer 52 anthropometric 52 interindividual variability 52 placebo fluoxetine 52 nicotine metabolite 52 decrements 52 hypogonadal 52 SLNB 52 serum cholesterol 52 Preoperatively 52 elevated serum creatinine 51 IL#B 51 anovulatory infertility 51 dysthymia 51 pericardial effusion 51 arterial thromboembolic events 51 cTnI 51 multivariate adjusted 51 linear regression 51 CARDIA 51 serum sodium 51 renal insufficiency 51 clinicopathologic 51 dyads 51 BENICAR HCT 51 lipid lowering medications 51 polyp recurrence 51 virologic response 51 lymphovascular invasion 51 density lipoprotein cholesterol 51 extubation 51 plain radiographs 51 pg ml 51 DAS# CRP 51 = #.#-#.# 51 NHANES 51 hemorrhagic complications 51 impaired insulin secretion 51 5 HTTLPR 51 androgen ablation 51 hallux valgus 51 r = 51 incomplete revascularization 51 Comorbidities 51 baroreflex 51 hydroxyvitamin D concentrations 51 lactate dehydrogenase 51 hemoglobin A1c HbA1c 51 Negative Syndrome 51 NNT = 51 #OHD 51 subthreshold depression 51 cerebral perfusion 51 serum aminotransferase levels 51 TNFalpha 51 NLSY 51 perimenopausal women 51 actigraphy 51 oral glucose tolerance 51 myocardial infarction MI 51 μg liter 51 warfarin therapy 51 death reinfarction 51 Unified Parkinson Disease 51 #q# deletion 51 lymphocyte count 51 genotype 51 methacholine 51 noncardiac 51 sputum eosinophils 51 Heavy menstrual bleeding 51 androgen depletion 51 CLBP 51 Geriatric Depression 51 UGT#A# * 51 NHANES surveys 51 hepatocellular carcinomas 51 â ‰ ¥ 51 stone formers 51 atopic